Literature DB >> 25497401

A novel mitochondrial DNA m.7507A>G mutation is only pathogenic at high levels of heteroplasmy.

Beverly Jo McCann1, Helen A L Tuppen2, Benno Küsters3, Martin Lammens4, Jan A M Smeitink5, Robert W Taylor2, Richard J Rodenburg5, Saskia B Wortmann6.   

Abstract

We present a Dutch family with a novel disease-causing mutation in the mitochondrial tRNA(Ser(UCN)) gene, m.7507A>G. The index patient died during the neonatal period due to cardio-respiratory failure and fatal lactic acidosis. A second patient, his cousin, has severe hearing loss necessitating cochlear implants and progressive exercise intolerance. Laboratory investigations of both patients revealed combined deficiencies of the enzyme complexes of the mitochondrial respiratory chain in several tissues. Reduced levels of fully assembled complexes I and IV in fibroblasts by BN-PAGE associated with (near) homoplasmic levels of the m.7507A>G mutation in several tissues and a severe reduction in the steady-state level of mt-tRNA(Ser(UCN)) in fibroblasts were observed. The novel mitochondrial DNA mutation was shown to segregate with disease; several healthy maternal family members showed high heteroplasmy levels (up to 76 ± 4% in blood and 68 ± 4% in fibroblasts) which did not lead to any alterations in the activities of the enzyme complexes of the respiratory chain in fibroblasts or clinical signs and symptoms. We hereby conclude that the m.7507A>G mutation causes a heterogeneous clinical phenotype and is only pathogenic at very high levels of mtDNA heteroplasmy.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hearing loss; Heteroplasmy; Mitochondrial tRNA; OXPHOS; Threshold effect

Mesh:

Substances:

Year:  2014        PMID: 25497401     DOI: 10.1016/j.nmd.2014.11.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  1 in total

1.  Investigating the influence of mtDNA and nuclear encoded mitochondrial variants on high intensity interval training outcomes.

Authors:  N Eynon; L R Griffiths; N R Harvey; S Voisin; R A Lea; X Yan; M C Benton; I D Papadimitriou; M Jacques; L M Haupt; K J Ashton
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.